Evaluating the effects of cannabis use in cancer patients receiving treatment
Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics
This study is looking at how cannabis and its compounds can help cancer patients feel better during their treatment, focusing on both the good and any possible downsides, so we can learn more about how it affects their symptoms and overall experience.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-10932967 on NIH RePORTER |
What this research studies
This research investigates how cannabis and cannabinoids affect cancer patients who are undergoing treatment in community oncology clinics. It aims to assess both the benefits and potential harms of cannabis use, particularly focusing on symptom relief for physical and neuropsychiatric issues that are often inadequately managed by conventional medications. By analyzing patient experiences and outcomes, the study seeks to provide clearer evidence on the efficacy and safety of cannabis products, which vary widely in composition and effects. The research will involve collecting data from a cohort of cancer patients to better understand their usage patterns and the impact on their treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients aged 21 and older who are currently undergoing treatment and considering or using cannabis for symptom relief.
Not a fit: Patients who are not currently undergoing cancer treatment or those who do not use cannabis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide valuable insights into the safe and effective use of cannabis for symptom management in cancer patients.
How similar studies have performed: While there is ongoing debate about the efficacy of cannabis in medical settings, this research aims to fill gaps in existing literature, suggesting that it may provide new insights rather than simply replicating previous findings.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Reboussin, Beth a. — Wake Forest University Health Sciences
- Study coordinator: Reboussin, Beth a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.